Capital Flow Monitor · Sponsors · CIK 1819114
Optimeos Life Sciences, Inc.
174 NASSAU STREET, SUITE 334, PRINCETON, NJ, 08542 · 609-658-9839
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$2.0M
Sold
$1.0M
% sold
50.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | D ·current | 506(b) | $2.0M | $1.0M | 50.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Shahram Hejazi — Executive Officer / Director, Princeton, NJ
- Robert K Prud'homme — Director, Princeton, NJ
-
Jason Smith — Director, Princeton, NJ
9 other raises
- TFC Big Gulps Mustang, LLC $700K of $700K · 100.0%
- TFC Desert Color, LLC $350K of $350K · 100.0%
- Cyrus Biotechnology, Inc. $1.5M of $3.0M · 49.4%
- SponsorCX, Inc. $4.1M of $5.0M · 82.8%
- TFC Westminster Oil 2 LLC $445K of $445K · 100.0%
- TFC Syracuse Big Gulps LLC $850K of $850K · 100.0%
- TFC Zaragoza KC LLC $750K of $750K · 100.0%
- TFC Belle Creek LLC $375K of $375K · 100.0%
- TFC Big Gulps LLC $730K of $730K · 100.0%
- Benjamin Doranz — Director, Princeton, NJ
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.